Physician profile
Archana Kumar
NPI 1326116286
$3,702.41
in general payments reported to CMS, 2019-2025
15 companies · $74.68 in 2025
The $74.68 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2021: $359 · 2022: $285 · 2023: $541 · 2024: $966 · 2025: $74.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,581.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,448.26 | 2019-2024 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $705.23 | 2019-2024 | Ingrezza |
| Alkermes, INC. | $296.79 | 2023-2024 | Aristada, Lybalvi, Vivitrol |
| Lundbeck LLC | $236.32 | 2021-2024 | Abilify Maintena, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $190.97 | 2021-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $179.15 | 2022-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Teva Pharmaceuticals USA, INC. | $172.26 | 2022-2024 | Uzedy, Austedo Xr, Austedo |
| Vanda Pharmaceuticals INC. | $145.10 | 2019-2024 | Hetlioz, Fanapt |
| Indivior INC. | $112.55 | 2023-2024 | Perseris |
| E.R. Squibb & Sons, L.L.C. | $103.23 | 2024-2025 | Cobenfy |
| Sunovion Pharmaceuticals INC. | $40.36 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $30.01 | 2019 | |
| Uswm, LLC | $16.17 | 2021 | |
| Almatica Pharma LLC | $13.88 | 2024 | Loreev Xr |
| Neuronetics, INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archana Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.